6.91
Finanzdaten der Envveno Medical Corp-Aktie (NVNO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
|
|
11.84%
1.72
|
1.951 | 2.065 | 2.298 | 4.158 |
| Operating Income/Loss |
6.55%
-3.796
|
-4.062 | -4.013 | -4.883 | -7.049 |
| Nonoperating Income/Loss |
7.98%
0.196
|
0.213 | 0.277 | 0.344 | 0.355 |
| Net Income/Loss |
6.47%
-3.60
|
-3.849 | -3.736 | -4.539 | -6.694 |
| Basic Average Shares |
2.60%
0.671
|
0.654 | - | 20.16 | 20.35 |
| Diluted Average Shares |
2.60%
0.671
|
0.654 | - | 20.16 | 20.35 |
| Basic Earnings Per Share |
8.83%
-5.37
|
-5.89 | - | -0.23 | -0.33 |
| Diluted Earnings Per Share |
8.83%
-5.37
|
-5.89 | - | -0.23 | -0.33 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):